Latest Incretin Stories
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com San Diego, CA (PRWEB) May 22, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing updated information for patients taking the medication Byetta. The FDA is investigating whether drugs like this are related to cancer after a study found pre-cancerous cells present in patient deaths*. The goal of DrugRisk is to improve the safety...
Gilman Law LLP is Investigating Byetta Lawsuits on Behalf of Victims of Pancreatic Cancer Side Effects, Allegedly Associated with Byetta, Januvaia, Victoza, and other Diabetes Drugs Known as Incretin Mimetics. Boston, MA (PRWEB) May 20, 2013 Gilman Law LLP, a leading pharmacy law and defective drug plaintiffs’ law firm investigating Byetta lawsuits, is troubled by a new study that reveals that pancreatic cancer reports associated with Byetta and similar type 2 diabetes drugs are...
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Los Angeles, CA (PRWEB) May 20, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for those taking the medications Januvia or Janumet. The FDA is investigating whether these drugs are related to cancer after a study found pre-cancerous cell growth in patients who had died*. DrugRisk was created to...
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Sacramento, CA (PRWEB) May 14, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing updated information for patients who have taken the medication Byetta. The maker of the drug has agreed with moving the growing number of injury claims to a special federal court in California*. DrugRisk was created to improve the safety of those...
Consumer inquiries about legal rights increase after FDA announces investigation into Januvia and other diabetes drugs over research study linking medications to pancreatitis. Free legal consultations now being offered by Resource4thePeople national network of attorneys. San Diego, CA (PRWEB) May 10, 2013 http://www.resource4thepeople.com/defectivedrugs/januvia.html Resource4thePeople announced today that its attorneys are offering free legal consultations to patients who used a certain...
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Los Angeles, CA (PRWEB) May 10, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for those taking the medications Januvia or Janumet. The maker of the drugs has agreed to move a growing number of injury claims to a special federal court in California*. DrugRisk was created to improve patient...
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Los Angeles, CA (PRWEB) May 04, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing updated information for patients who have taken the medication Byetta. A recent study suggests the drug may have higher occurrence rates of pancreatic cancer and thyroid cancer than traditional treatments. DrugRisk was created to improve the...
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com Los Angeles, CA (PRWEB) May 02, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing new information on the site for those taking the medication Januvia. A recent study suggests the drug may have higher occurrence rates of pancreatitis and pancreatic cancer than traditional pills****. DrugRisk was created to improve patient...
DrugRisk is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) April 20, 2013 The diabetes drug safety advocates at DrugRisk.com are announcing the launch of a new resource center for patients who have taken the medication Byetta, amid warnings that the drug may be related to pancreatic cancer and thyroid cancer. DrugRisk was created to improve the safety of those taking popular...
According to the Institute for Safe Medication Practices’ most recent QuarterWatch report, incretin mimetic drugs such as Byetta, Januvia and Victoza may be 25 times more likely to be linked to pancreatic cancer. This class of medications is currently under investigation by the U.S. Food and Drug Administration (FDA) after researchers found evidence of precancerous cell changes in pancreatic tissue samples from patients who took the Type 2 diabetes drugs. New York, New York (PRWEB) April...
